[27V11-pm] リスクマネジメント/医薬品情報/薬物治療（がん）①

Sat. Mar 27, 2021 3:03 PM - 4:39 PM [Room V11] Oral Presentation 11 (Online)

座長：河原昌美（愛知学院大薬）、内田まやこ（大阪薬大）

+Add all to schedule

3:03 PM - 3:15 PM

[27V11-pm10S] The effects of drug name similarity and therapeutic categories on dispensing errors

○Haruka Sagawa¹, Tadamasa Kamimura², Shinya Suzuki³, Seiichi Hayashi², Koudai Yoshikawa¹, Hayato Kizaki¹, Satoko Hori¹ (1. Keio University Faculty of Pharmacy, 2. Pharmaceutical department, Keiyu Hospital, 3. Pharmaceutical Department, Showa University Northern Yokohama Hospital)

3:15 PM - 3:27 PM

[27V11-pm11S] Trend in companies based on comparison between the actual status of information provision and collection activities of medical science liaison (MSL) and frequency of activities of medical representative (MR).

○Manako Doi¹, Shinichi Watanabe², Hiroki Iwata^1,3, Noriko Kobayashi^1,3, Kazuko Fujimoto¹, Katsunori Yamaura^1,3 (1. Keio Univ Faculty Pharm, 2. Teikyo Heisei Univ Pharm, 3. Keio Univ Commun Pharm )

3:27 PM - 3:39 PM

[27V11-pm12S] Modulation of oxidative stress as a potential therapeutic strategy for triple-negative breast cancer and drug repositioning

○Chinami Ikushima¹, Nene Inagaki¹, Myuu Ogata¹, Shiori Goto¹, Chihiro Matsui¹, Reiko Yutani¹, Haruka Otsuka¹, Haruki Torii¹, Ikuhiko Nakase², Tomoka Takatani-Nakase^1,3 (1. Dept. Pharm., Mukogawa Women's Univ., 2. Grad. Sch. Sci., Osaka Prefecture Univ., 3. Inst. Biosci., Mukogawa Women's Univ.)

3:39 PM - 3:51 PM

[27V11-pm13S] The incidence of cardiotoxicity and risk factors in breast cancer with perioperative adjuvant chemotherapy.

○Yukari Mori¹, Yuusuke Tashiro², Yuji Hotta^1,2, Tomoka Hisada³, Sayaka Nishikawa³, Takafumi Nakayama³, Naoto Kondo³, Kazunori Kimura^1,2,3 (1. Grad. Sch. Pharm Sci., Nagoya City Univ., 2. Dept. Pharm., Nagoya City Univ. Hosp., 3. Grad. Sch. Med Sci., Nagoya City Univ.)

3:51 PM - 4:03 PM

[27V11-pm14S] Therapeutic potency and mechanisms of polyI:C in the treatment of triple negative breast cancer

○Yusuke Tamura¹, Masato Morikawa¹, Ryo Tanabe¹, Daizo Koinuma¹, Kohei Miyazono¹ (1. Dept. Mol. Path., Grad. Sch. Med., Univ. Tokyo)

4:03 PM - 4:15 PM

[27V11-pm15] Two cases caused rash by atezolizumab + nab-paclitaxel therapy for breast cancer controlled by premedication of diphenhydramine and regular administration of olopatadine

○Ayami Inomata¹, Masanori Motonaga¹, Ryo Itamura¹, Tomoko Okamoto¹, Ryohei Kobayashi¹, Yusuke Teratani¹, Yasuyuki Saeki¹, Hiroaki Matsuo¹ (1. Dept. Pharm. Serv., Hiroshima Univ. Hosp.)

Withdrawn

4:15 PM - 4:27 PM

[27V11-pm16S] [Withdrawn]

4:27 PM - 4:39 PM

[27V11-pm17S] PI3K/Akt pathway activation is involved with MEK inhibitor resistance in colorectal carcinoma

○yuta yamamoto¹, Masanobu Tsubaki¹, Tomoya Takeda¹, Yusuke Morii¹, Katsumasa Tsurushima¹, Shozo Nishida¹ (1. Dept. of Pharmacotherapy, Fac of Pharmacy, Kindai Univ.)

Session information